An overview of methods for comparative effectiveness research

Seminars in Radiation Oncology

Volumn 24, Issue 1, 2014, Pages 5-13

  Meyer, Anne Marie ^a,b   Wheeler, Stephanie B ^a,b   Weinberger, Morris ^a,c   Chen, Ronald C ^b,d   Carpenter, William R ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL DECISION MAKING; CLINICAL RESEARCH; COMPARATIVE EFFECTIVENESS; HUMAN; INFORMED CONSENT; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME;

CASE-CONTROL STUDIES; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; HUMANS; NEOPLASMS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84888856371     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2013.09.002     Document Type: Article

References (53)

1. Minasian L.M., Carpenter W.R., Weiner B.J., et al. Translating research into evidence-based practice: The National Cancer Institute Community Clinical Oncology Program. Cancer 2010, 116(19):4440-4449.
2. Initial National Priorities for Comparative Effectiveness Research 2009, Institute of Medicine, National Academies Press, Washington, DC.
3. Lohr K.N. Emerging methods in comparative effectiveness and safety-Symposium overview and summary. Med Care 2007, 45(10):S5-S8.
4. Luce B.R., Kramer J.M., Goodman S.N., et al. Rethinking randomized clinical trials for comparative effectiveness research: The need for transformational change. Ann Intern Med 2009, 151(3):206-W245.
5. Basch E., Aronson N., Berg A., et al. Methodological standards and patient-centeredness in comparative effectiveness research: The PCORI perspective. J Am Med Assoc 2012, 307(15):1636-1640.
6. Chang S.M. The Agency for Healthcare Research and Quality (AHRQ) Effective Health Care (EHC) program methods guide for comparative effectiveness reviews: Keeping up-to-date in a rapidly evolving field. J Clin Epidemiol 2011, 64(11):1166-1167.
7. Abernethy A.P., Etheredge L.M., Ganz P.A., et al. Rapid-learning system for cancer care. J Clin Oncol 2010, 28(27):4268-4274.
8. Meyer A.M., Carpenter W.R., Abernethy A.P., et al. Data for cancer comparative effectiveness research. Cancer 2012, 118(21):5186-5197.
9. Hershman D.L., Wright J.D. Comparative effectiveness research in oncology methodology: Observational data. J Clin Oncol Dec 2012, 30(34):4215-4222.
10. Thorpe K.E., Zwarenstein M., Oxman A.D., et al. A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. J Clin Epidemiol 2009, 62(5):464-475.
11. Sox H.C., Goodman S.N. The methods of comparative effectiveness research. Ann Rev Public Health 2012, 33:425-445.
12. Initial National Priorities for Comparative Effectiveness Research 2009, Institue of Medicine, National Academies Press, Washington, DC.
13. Chen R.C. Comparative effectiveness research in oncology: the promise, challenges, and opportunities. Semin Radiat Oncol 2014, 24(1):1-4.
14. Campbell M.K., Elbourne D.R., Altman D.G. CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328(7441):702-708.
15. Ukoumunne O.C., Gulliford M.C., Chinn S., et al. Methods for evaluating area-wide and organisation-based interventions in health and health care: A systematic review. Health Technol Assess 1999, 3(5):iii-92.
16. Campbell M.K., Elbourne D.R., Altman D.G., et al. CONSORT statement: Extension to cluster randomised trials. BMJ 2004, 328(7441):702-708.
17. Campbell M.K., Piaggio G., Elbourne D.R., et al. Consort 2010 statement: Extension to cluster randomised trials. BMJ 2012, 5:e5661.
18. Wells K.J., Lee J.H., Calcano E.R., et al. A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev 2012, 21(10):1664-1672.
19. Hutson S. A change is in the wind as "adaptive" clinical trials catch on. Nat Med 2009, 15(9):977.
20. Berry D.A. Adaptive clinical trials: the promise and the caution. J Clin Oncol 2011, 29(6):606-609.
21. Carpenter W.R., Meyer A.M., Abernethy A.P., et al. A framework for understanding cancer comparative effectiveness research data needs. J Clin Epidemiol 2012, 65(11):1150-1158.
22. Brookhart M.A., Wyss R., Layton J.B., Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes 2013, 6(5):604-611.
23. Sturmer T., Rothman K.J., Glynn R.J. Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf 2006, 15(10):698-709.
24. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70(1):41-55.
25. Sturmer T., Schneeweiss S., Avorn J., et al. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol 2005, 162(3):279-289.
26. Schroeder J.C., Bensen J.T., Su L.J., et al. The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate 2006, 66(11):1162-1176.
27. Malin J.L., Ko C., Ayanian J.Z., et al. Understanding cancer patients' experience and outcomes: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 2006, 14(8):837-848.
28. Sanoff H.K., Carpenter W.R., Martin C.F., et al. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst 2012, 104(3):211-227.
29. Sheets N.C., Goldin G.H., Meyer A.M., et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. J Am Med Assoc 2012, 307(15):1611-1620.
30. Hernan M.A., Alonso A., Logan R., et al. Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008, 19(6):766-779.
31. Walker A.M. Confounding by indication. Epidemiology 1996, 7(4):335-336.
32. Signorello L.B., McLaughlin J.K., Lipworth L., et al. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002, 9(3):199-205.
33. D'Agostino R.B. Stat Med 1998, 17(19):2265-2281.
34. Sturmer T., Rothman K.J., Avorn J., et al. Treatment effects in the presence of unmeasured confounding: Dealing with observations in the tails of the propensity score distribution-A simulation study. Am J Epidemiol 2010, 172(7):843-854.
35. Glynn R.J., Schneeweiss S., Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 2006, 98(3):253-259.
36. Newhouse J.P., McClellan M. Econometrics in outcomes research: The use of instrumental variables. Ann Rev Public Health 1998, 19:17-34.
37. Brookhart M.A., Rassen J.A., Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Safe 2010, 19(6):537-554.
38. Brouwers M.C., Thabane L., Moher D., et al. Comparative effectiveness research paradigm: Implications for systematic reviews and clinical practice guidelines. J Clin Oncol 2012, 30(34):4202-4207.
39. Clinical Practice Guidelines We Can Trust 2011, Institute of Medicine, National Academies Press, Washington, DC. R. Graham, M. Mancher, D. Wolman (Eds.).
40. Relevo R., Balshem H. Finding evidence for comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol 2011, 64(11):1168-1177.
41. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med Apr 2001, 20(suppl 3):21-35.
42. Higgins J., Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2 2009, Wiley & Sons, Hoboken, NJ.
43. Finding What Works in Health Care: Standards for Systematic Reviews 2011, Institute of Medicine, The National Academies Press, Washington, DC.
44. Armstrong K. Methods in comparative effectiveness research. J Clin Oncol 2012, 30(34):4208-4214.
45. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001, 134(8):663-694.
46. Vandenbroucke J.P., von Elm E., Altman D.G., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 2007, 147(8):W163-W194.
47. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315(7121):1533-1537.
48. Egger M., Smith G.D. Meta-Analysis. Potentials and promise. BMJ 1997, 315(7119):1371-1374.
49. Ragsdale C. Spreadsheet Modeling & Decision Analysis: A Practical Introduction to Management Science 2010, Cengage Learning, Mason, OH. ed 6.
50. Chumney E., Simpson K. Methods and Designs for Outcomes Research 2006, American Society of Health System Pharmacists, Bethesda, MD.
51. Drummond M, Sculpher M, Torrance G,et al: Methods for the Economic Evaluation of Health Care Programmes (ed 3). New York, Oxford University Press, 2005.
52. Muennig P. Cost-Effectiveness Analysis in Health: A Practical Approach 2008, Jossey-Bass, San Francisco.
53. Sher D.J., Punglia R.S. decision analysis and cost-effectiveness analysis for comparative effectiveness research-a primer. Semin Radiat Oncol 2014, 24(1):14-24.